Navigation Links
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
Date:1/15/2014

DUBLIN, January 15, 2014 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has waived the Office of Fair Trading (OFT) approval condition to the announced tender offer for all of the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).  

As a result of the waiver, the transaction is no longer conditional on OFT approval, and Shire expects to complete the tender offer on January 24, 2014 following the currently scheduled expiration time, subject to the satisfaction of all of the remaining conditions to the tender offer.  The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) expired on December 10, 2013.  

The tender offer is scheduled to expire at midnight, New York City time, on Thursday, January 23, 2014 (one minute after 11:59 p.m., New York City time, on January 23, 2014).

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

http://www.shire.com


ADDITIONAL INFORMATION AND WHERE TO FIND IT  

This announcement is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell ViroPharma common stock. The offer to buy ViroPharma common stock is being made pursuant to a tender offer statement (including the offer to purchase, letter of transmittal and other related t
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
2. Shire Extends Tender Offer for ViroPharma
3. Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
4. MinuteClinic Opens First Clinic Locations in New Hampshire
5. Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
6. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
7. Shire to Present at the Morgan Stanley Global Healthcare Conference
8. Shire Reports 7% Product Sales Growth: Anticipating Double Digit Non GAAP Earnings Growth in 2013
9. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
10. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
11. SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015  Fort Lauderdale-based investment ... to announce that its Consumer Group completed the ... Kerry Group plc (ISE: KRZ) ("Kerry"), one of ... nutrition systems, as well as functional ingredients and ... markets. Farlie Turner served as the exclusive financial ...
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ... Market by Analog, Application, End-User & by Region - Global ... This market is projected to reach about $2.5 ... different applications and rising opportunities in countries such as ... Italy , and Brazil . ...
(Date:7/2/2015)... , July 2, 2015 Pharma Major ... in ZAO "Biocom" in Russia subject ... the Russian pharmaceutical market which recorded RUB 765 billion in ... markets in the world in 2014 (IMS Health). For over ... expected to continue with this trend, projecting Russia ...
Breaking Medicine Technology:Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
... the leading Health Image Intelligence™ company, announces that it will ... International Definiens Symposium at the Moffitt Cancer Center ... the premier forum for Definiens users and developers from around ... in life science image and data analysis. One focus of ...
... www.theravasc.com ) announced the successful completion of a Phase I ... trial included 12 diabetic patients who each received a single ... coated and a non-enteric coated capsule, to determine safety and ... in animals, the circulating blood levels in all patients were ...
Cached Medicine Technology:Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium 2Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium 3TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients 2
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and a generous grant ... Music & Memory Certification for hospice patients and adult day center participants. , The ... to patients but also to their families and volunteers. Music & Memory is a ...
(Date:7/5/2015)... ... July 05, 2015 , ... ... the Weed Master, a landscaping invention that effectively removes weeds without harming ... dollars," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It ...
(Date:7/4/2015)... , ... July 04, 2015 , ... Chronic Neck Pain. ... chronic pain sufferers have pain located in the neck. Another 19% suffer from head, ... Chiropractic literature suggests that 45% of American workers must deal with neck ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
Breaking Medicine News(10 mins):Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... Other alcohol also boosted the risk, as did smoking, ... Heavy smoking and drinking, especially beer, may hasten the ... their data Tuesday at the Digestive Disease Week 2008 ... a stronger influence than hard liquor or wine in ...
... teamed up to develop the first ever evidence-based ... hope that it will aid future diagnosis, treatment ... study, conducted by the Standards Committee of the ... published online by ,two leading Wiley-Blackwell publications, the ...
... Simon, M.D. will teach the essential tools for stress relief and peace of ... ... This May 23-25, the Chopra Center for,Wellbeing is coming to New York City ... David,Simon, will help guests discover their personal path to true health and,well-being., ...
... -- Benda,Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a ... medicine for the treatment of cancer, and traditional ... the quarter,ended March 31, 2008. The Company filed ... 2008., Three Months Ended March 31, 2008, ...
... HARRISBURG, Pa., May 21 As fast-food marketers ... chicken breakfast,sandwiches to a time-pressured society -- one ... -- Capital BlueCross is responding by extending an,innovative ... across the,state and the nation., Two years ...
... Licensed Eye Care ... Professionals Only, LARGO, Fla., May 21 ... develops,licenses, manufactures, distributes and markets specialty contact lenses,today announced the launch of ... disposable contact lens sold under the C-VUE brand., Unilens, known as ...
Cached Medicine News:Health News:Beer Drinking May Speed Pancreatic Cancer Onset 2Health News:Beer Drinking May Speed Pancreatic Cancer Onset 3Health News:Beer Drinking May Speed Pancreatic Cancer Onset 4Health News:Experts from 10 countries develop first evidence-based definition of lifelong premature ejaculation 2Health News:Experts from 10 countries develop first evidence-based definition of lifelong premature ejaculation 3Health News:The Chopra Center Co-founders Bring Mind-Body Healing to New York City 2Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 2Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 3Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 4Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 5Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 6Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 7Health News:Capital BlueCross Goes National for Health 2Health News:Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens 2